TORONTO, Oct. 30, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics (TSX-V:CTH) (the “Company”), the developer of novel cannabinoid-based pharmaceutical products, today announced that George Nomikos, former Scientific Director at Amgen, Inc. has been appointed as Senior Director, Scientific Affairs. Dr. Nomikos has published more than 140 papers in the field of Neuroscience, Neuropsychopharmacology and Cannabinoid Therapeutics, and brings invaluable knowledge and experience to the Cannasat drug development team.
